Skip to contents

Brendan Everett, MD, MPH
Associate Physician, Brigham and Women's Hospital
Assistant Professor of Medicine, Harvard Medical School

Brigham and Women's Hospital
Department of Medicine
Cardiovascular
75 Francis Street
Boston, MA 02115


Edit Profile


Education:
Harvard Medical School, 2000

Publications (Pulled from Harvard Catalyst Profiles):

1. Li D, Yoshida K, Feldman CH, Speyer C, Barbhaiya M, Guan H, Solomon DH, Everett BM, Costenbader KH. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus. Rheumatology (Oxford). 2019 Jul 18.

2. Chen SK, Barbhaiya M, Fischer MA, Guan H, Yoshida K, Feldman CH, Costenbader KH, Everett BM. Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general medicaid patients. Semin Arthritis Rheum. 2019 Jun 11.

3. Everett BM. Residual Inflammatory Risk: A Common and Important Risk Factor for Recurrent Cardiovascular Events. J Am Coll Cardiol. 2019 May 21; 73(19):2410-2412.

4. Aday AW, Everett BM. Dyslipidemia Profiles in Patients with Peripheral Artery Disease. Curr Cardiol Rep. 2019 Apr 22; 21(6):42.

5. Low Wang CC, Everett BM, Burman KD, Wilson PWF. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs? Circulation. 2019 Apr 02; 139(14):1741-1743.

6. Libby P, Everett BM. Novel Antiatherosclerotic Therapies. Arterioscler Thromb Vasc Biol. 2019 Apr; 39(4):538-545.

7. Everett BM, Siddiqi HK. Heart Failure, the Inflammasome, and Interleukin-1ß: Prognostic and Therapeutic? J Am Coll Cardiol. 2019 Mar 12; 73(9):1026-1028.

8. Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation. 2019 Mar 05; 139(10):1289-1299.

9. Chen SK, Barbhaiya M, Fischer MA, Guan H, Lin TC, Feldman CH, Everett BM, Costenbader KH. Lipid Testing and Statin Prescriptions Among Medicaid Recipients With Systemic Lupus Erythematosus or Diabetes Mellitus and the General Medicaid Population. Arthritis Care Res (Hoboken). 2019 Jan; 71(1):104-115.

10. Das SR, Everett BM, Birtcher KK, Brown JM, Cefalu WT, Januzzi JL, Kalyani RR, Kosiborod M, Magwire ML, Morris PB, Sperling LS. 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018 Dec 18; 72(24):3200-3223.